Richard, S., Gaballa, M., Gregory, T., Chhabra, S., Anderson, L., Costa, L., Costello, C., Goldsmith, S., Hansen, D., Rajeeve, S., Kumar, S., Ramakrishnan, A., Battiwalla, M., Nooka, A., Shaikh, H., Hong, M. G., Wang, S., Cheung, P., Li, L., Dhakal, B. (2025). Safety and efficacy of AZD0120, a BCMA/CD19 dual-targeting CAR T-cell therapy, in relapsed/refractory multiple myeloma: Preliminary Results from the DURGA-1 Phase 1b/2 study. Blood. https://doi.org/10.1182/blood-2025-269